HLT: HLT begins enrolment in clinical trial of Meridian valve and Pathfinder II for aortic stenosis
US-based medical device firm HLT has started patient enrolment in a feasibility clinical study (RADIANT) of its Meridian transcatheter aortic valve and Pathfinder II delivery system to treat severe aortic stenosis.
Read full article »
President & CEO
Bradley Fox
HLT is a medical device firm that develops transcatheter valve technology for treatment of aortic procedure.
Read more